Clinical Trial Update: Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a three-drug combination (bortezomib, sorafenib tosylate, and decitabine) in adults with acute myeloid leukemia, including the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Therapy-related Acute Myeloid Leukemia

Drugs mentioned

• Bortezomib (bortezomib)
• Decitabine (Decitabine)
• Nexavar (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy | Phase 1 | Status: ACTIVE_NOT_RECRUITING